Julie K. Andersen

ORCID: 0000-0003-1324-4875
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Parkinson's Disease Mechanisms and Treatments
  • Genetics, Aging, and Longevity in Model Organisms
  • Alzheimer's disease research and treatments
  • Nerve injury and regeneration
  • Mitochondrial Function and Pathology
  • Neuroscience and Neuropharmacology Research
  • Nuclear Receptors and Signaling
  • Autophagy in Disease and Therapy
  • Neurological diseases and metabolism
  • Sulfur Compounds in Biology
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Telomeres, Telomerase, and Senescence
  • RNA regulation and disease
  • Genetic Neurodegenerative Diseases
  • Virus-based gene therapy research
  • Tryptophan and brain disorders
  • Neurological disorders and treatments
  • Iron Metabolism and Disorders
  • Paraquat toxicity studies and treatments
  • Pluripotent Stem Cells Research
  • Redox biology and oxidative stress
  • Trace Elements in Health
  • Pomegranate: compositions and health benefits
  • Cholinesterase and Neurodegenerative Diseases
  • Circadian rhythm and melatonin

Buck Institute for Research on Aging
2016-2025

University of Southern California
2000-2024

Marin Community Foundation
2014-2023

Roche (Switzerland)
2017

Evotec (Germany)
2017

University of Puerto Rico, Medical Sciences Campus
2010

San Jose State University
2006

Massachusetts General Hospital
1991-2002

Brigham Young University
2000

The Pirbright Institute
1999

Glutathione peroxidase (GSHPx) is a critical intracellular enzyme involved in detoxification of hydrogen peroxide (H(2)O(2)) to water. In the present study we examined susceptibility mice with disruption glutathione gene neurotoxic effects malonate, 3-nitropropionic acid (3-NP), and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP). knock-out showed no evidence neuropathological or behavioral abnormalities at 2-3 months age. Intrastriatal injections malonate resulted significant twofold...

10.1523/jneurosci.20-01-00001.2000 article EN cc-by-nc-sa Journal of Neuroscience 2000-01-01

Exposure to the herbicide paraquat (PQ) is associated with an increased risk of idiopathic Parkinson's disease (PD). Therapies based on PQ's presumed mechanisms action have not, however, yielded effective therapies. Cellular senescence anticancer mechanism that arrests proliferation replication-competent cells and results in a pro-inflammatory senescence-associated secretory phenotype (SASP) capable damaging neighboring tissues. Here, we demonstrate senescent cell markers are preferentially...

10.1016/j.celrep.2017.12.092 article EN cc-by-nc-nd Cell Reports 2018-01-01

Aging is associated with changes in circulating levels of various molecules, some which remain undefined. We find that concentrations taurine decline aging mice, monkeys, and humans. A reversal this through supplementation increased the health span (the period healthy living) life mice monkeys. Mechanistically, reduced cellular senescence, protected against telomerase deficiency, suppressed mitochondrial dysfunction, decreased DNA damage, attenuated inflammaging. In humans, lower correlated...

10.1126/science.abn9257 article EN Science 2023-06-08

Parkinson's disease (PD) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity are both associated with dopaminergic neuron death in the substantia nigra (SN). Apoptosis has been implicated this cell loss; however, whether or not it is a major component of pathology remains controversial. Caspases class proteases involved apoptotic process. To evaluate role caspases PD, we analyzed caspase activation MPTP-treated mice, cultured cells, postmortem PD brain tissue. MPTP was found to...

10.1523/jneurosci.21-24-09519.2001 article EN cc-by-nc-sa Journal of Neuroscience 2001-12-15

Abstract Systemic treatment of mice with the herbicide paraquat causes selective loss nigrostriatal dopaminergic neurons, reproducing primary neurodegenerative feature Parkinson's disease. To elucidate role oxidative damage in neurotoxicity, time‐course neurodegeneration was correlated to changes 4‐hydroxy‐2‐nonenal (4‐HNE), a lipid peroxidation marker. When were exposed three weekly injections paraquat, no nigral cell observed after first administration, whereas significant reduction...

10.1111/j.1471-4159.2005.03088.x article EN Journal of Neurochemistry 2005-04-22

Age-related increases in monoamine oxidase B (MAO-B) may contribute to neurodegeneration associated with Parkinson's disease (PD). The MAO-B inhibitor deprenyl, a long-standing antiparkinsonian therapy, is currently used clinically concert the dopamine precursor L-DOPA. Clinical studies suggesting that deprenyl treatment alone not protective against PD mortality were targeted symptomatic patients. However, loss at least 60% by time symptomatically detectable, therefore lack of effect...

10.1371/journal.pone.0001616 article EN cc-by PLoS ONE 2008-02-20

Oxidative stress appears to play an important role in degeneration of dopaminergic neurons the substantia nigra (SN) associated with Parkinson's disease (PD). The SN early PD patients have dramatically decreased levels thiol tripeptide glutathione (GSH). GSH plays multiple roles nervous system both as antioxidant and a redox modulator. We generated PC12 cell lines which can be inducibly down-regulated via doxycycline induction antisense messages against heavy light subunits...

10.1074/jbc.m000120200 article EN cc-by Journal of Biological Chemistry 2000-08-01

Environmental exposure to the oxidant-producing herbicide paraquat has been implicated as a risk factor in Parkinson's disease. Although intraperitoneal injections mice cause selective loss of dopaminergic neurons substantia nigra pars compacta, exact mechanism involved is still poorly understood. Our data show that induces sequential phosphorylation c-Jun N-terminal kinase (JNK) and activation caspase-3 neuronal death both vitro vivo. These effects are diminished by specific JNK inhibitor...

10.1074/jbc.m404596200 article EN cc-by Journal of Biological Chemistry 2004-07-01

Aging is a three-stage process: metabolism, damage, and pathology. The biochemical processes that sustain life generate toxins as an intrinsic side effect. These cause of which small proportion cannot be removed by any endogenous repair process thus accumulates. This accumulating damage ultimately drives age-related degeneration. Interventions can designed at all three stages. However, intervention in metabolism only modestly postpone pathology, because production so property metabolic...

10.1111/j.1749-6632.2002.tb02115.x article EN Annals of the New York Academy of Sciences 2002-04-01

Following its activation by PINK1, parkin is recruited to depolarized mitochondria where it ubiquitinates outer mitochondrial membrane proteins, initiating lysosomal-mediated degradation of these organelles. Mutations in the gene encoding parkin, PARK2, result both familial and sporadic forms Parkinson's disease (PD) conjunction with reductions removal damaged mitochondria. In contrast what has been reported for other PARK2 mutations, expression Q311X mutation vivo mice appears involve a...

10.1523/jneurosci.0109-15.2015 article EN cc-by-nc-sa Journal of Neuroscience 2015-09-16
Coming Soon ...